Stay updated on Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial
Sign up to get notified when there's something new on the Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial page.

Latest updates to the Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page revision tag was updated to v3.6.6, indicating an administrative update to the ClinicalTrials.gov record.SummaryDifference0.0%

- Check21 days agoChange DetectedAdded a link to the PHOENIX trial website that contains information about the trial and its participating centers. The sponsor attribution and related labeling were updated to list Biogen as sponsor and include a 'Helpful Links Provided by' note.SummaryDifference0.1%

- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe page now displays Revision: v3.6.5 instead of v3.6.4, indicating a small administrative update to the ClinicalTrials.gov record.SummaryDifference0.0%

- Check50 days agoChange DetectedThe page revision tag was updated from v3.6.3 to v3.6.4, indicating a minor update to the page’s documentation/versioning rather than a change to the study data itself.SummaryDifference0.0%

- Check71 days agoChange DetectedRevision label updated from v3.6.2 to v3.6.3, signaling a small update to the study record metadata.SummaryDifference0.0%

- Check78 days agoChange DetectedThe page’s revision tag was updated from v3.6.0 to v3.6.2. This indicates a newer version of the page's metadata rather than a substantive change to the study details.SummaryDifference0.1%

Stay in the know with updates to Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial page.